Panebianco, V., Briganti, A., Efstathiou, J., Galgano, S., Luk, L., Muglia, V. F., Redd, B., de Rooij, M., Takeuchi, M., Woo, S., Witjes, J. A., & Vargas, H. A. (2024). The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee. European Urology, 86(6), 485–487. https://doi.org/10.1016/j.eururo.2024.09.013

Papachristodoulou, A., Heidegger, I., Virk, R. K., Di Bernardo, M., Kim, J. Y., Laplaca, C., Picech, F., Schäfer, G., De Castro, G. J., Hibshoosh, H., Loda, M., Klocker, H., Rubin, M. A., Zheng, T., Benson, M. C., McKiernan, J. M., Dutta, A., & Abate-Shen, C. (2024). Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. European Urology, 85(4), 361–372. https://doi.org/10.1016/j.eururo.2023.07.016

Guo, C., Figueiredo, I., Gurel, B., Neeb, A., Seed, G., Crespo, M., Carreira, S., Rekowski, J., Buroni, L., Welti, J., Bogdan, D., Gallagher, L., Sharp, A., Fenor de la Maza, M. D., Rescigno, P., Westaby, D., Chandran, K., Riisnaes, R., Ferreira, A., … de Bono, J. S. (2023). B7-H3 as a Therapeutic Target in Advanced Prostate Cancer. European Urology, 83(3), 224–238. https://doi.org/10.1016/j.eururo.2022.09.004